Skyworks Solutions Inc. (NASDAQ:SWKS) should adopt a portfolio diversification in the analog space via acquisition that may well serve the next leg of opportunity. Skyworks Solutions Inc. (NASDAQ:SWKS) stock opened at $34.84 in last session, and closed at $35.46, while the day range of Skyworks Solutions Inc. (NASDAQ:SWKS) stock is $34.83 – $35.98. The stock showed a positive weekly performance of 8.37%.
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) VP Glenn Baity unloaded 42,000 shares of ACADIA Pharmaceuticals stock on the open market in a transaction dated Wednesday, February 26th. The shares were sold at an average price of $30.28, for a total transaction of $1,271,760.00. Following the completion of the sale, the vice president now directly owns 47,788 shares of the company’s stock, valued at approximately $1,447,021. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) stock opened at $29.20 in last session, and closed at $28.30 by losing -5.98%. The 52 week range of $6.02 – $32.00. Company’s market capitalization is $2.53B.
Rebekah Brooks, the ex-chief executive of News Corp. (NASDAQ:NWSA) British newspaper arm, told a London court on Friday she had paid a public official for a story about former Iraqi leader Saddam Hussein planning to attack Britain with the poison anthrax. News Corp. (NASDAQ:NWSA) stock increased 1.72% and finished the last session at $18.33. The EPS of the stock remained -1.04. Company’s market capitalization is $10.61B.
Shares of Clovis Oncology Inc. (NASDAQ:CLVS) reached a new 52-week high during mid-day trading on Friday after Leerink Swann raised their price target on the stock from $104.00 to $110.00, American Banking News reports. The stock traded as high as $88.99 and last traded at $81.34, with a volume of 2,030,929 shares traded. Clovis Oncology Inc. (NASDAQ:CLVS) stock opened the session at $81.10, and closed the session at $79.62. The 52 week range of the Clovis Oncology Inc. (NASDAQ:CLVS) stock remained $18.55 – $88.99 and the day range was $79.01 – $88.99.